Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.990
-0.180 (-5.68%)
At close: Nov 20, 2024, 4:00 PM
3.050
+0.060 (2.01%)
After-hours: Nov 20, 2024, 5:03 PM EST
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $381.51 million as of November 21, 2024. Its market cap has decreased by -50.22% in one year.
Market Cap
381.51M
Enterprise Value
247.23M
1-Year Change
-50.22%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $381.51M, a decrease of -76.56%. That is a compound annual growth rate of -50.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 381.51M | -53.31% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Esperion Therapeutics | 423.63M |
| Aquestive Therapeutics | 423.07M |
| Revance Therapeutics | 418.56M |
| DocGo | 408.20M |
| Contineum Therapeutics | 408.06M |
| KalVista Pharmaceuticals | 401.90M |
| Rigel Pharmaceuticals | 400.57M |
| Canopy Growth | 398.27M |